despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. . .
county grand jury report finds shortcomings in hepatitis response .
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful .